Home
Squadron Capital Management reported a 1.6% stake in NextCure NXTC · 64,464 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 1.6%
- Last report
- 9.9% · filed 26/02/17
- Shares held
- 64,464 sh
- Class
- Common Stock, $0.001 par value per share
- Stock
- NextCure NXTC
- Event date
- 26/06/30
- Filed
- 26/08/14
1.6% stake · below 5%
- Stake
- 1.6%
- Last report
- 9.9%
- Since last report
- −8.3pp
NextCure trades, last 26 weeks
What else happened in NextCure around then
Filed or reported within 30 days of the trade day · 05/31~07/30Squadron Capital Management's other 5% stake reports
- Squadron Capital Management
5% stakeTraws Pharma
5% stakeTraws Pharma
TRAW
0% stake
0 sh
0% stake
Filed 08/14
- Squadron Capital Management
5% stakeRelmada Therapeutics
5% stakeRelmada Therapeutics
RLMD
7% stake
7,350,000 sh
7% stake
Filed 08/14
- Squadron Capital Management
5% stakeLipocine
5% stakeLipocine
LPCN
9.8% stake
810,000 sh
9.8% stake
Filed 08/14
- Squadron Capital Management
5% stakeC4 Therapeutics
5% stakeC4 Therapeutics
CCCC
6.9% stake
7,600,000 sh
6.9% stake
Filed 08/14
- Squadron Capital Management
5% stakeQuince Therapeutics
5% stakeQuince Therapeutics
QNCX
5.6% stake
55,173 sh
5.6% stake
Filed 08/04
